Improving the Performance of Somatic Mutation Identification by Recovering Circulating Tumor DNA Mutations

Archive ouverte

Fu, Yu | Jovelet, Cécile | Filleron, Thomas | Pedrero, Marion | Motté, Nelly | Boursin, Yannick | Luo, Yufei | Massard, Christophe | Campone, Mario | Levy, Christelle | Diéras, Véronique | Bachelot, Thomas | Garrabey, Julie | Soria, Jean-Charles | Lacroix, Ludovic | André, Fabrice | Lefebvre, Celine

Edité par CCSD ; American Association for Cancer Research -

International audience. DNA extracted from cancer patients' whole blood may contain somatic mutations from circulating tumor DNA (ctDNA) fragments. In this study, we introduce cmDetect, a computational method for the systematic identification of ctDNA mutations using whole-exome sequencing of a cohort of tumor and corresponding peripheral whole-blood samples. Through the analysis of simulated data, we demonstrated an increase in sensitivity in calling somatic mutations by combining cmDetect to two widely used mutation callers. In a cohort of 93 breast cancer metastatic patients, cmDetect identified ctDNA mutations in 54% of the patients and recovered somatic mutations in cancer genes EGFR, PIK3CA, and TP53. We further showed that cmDetect detected ctDNA in 89% of patients with confirmed mutated cell–free tumor DNA by plasma analyses (n ¼ 9) within 46 pan-cancer patients. Our results prompt immediate consideration of the use of this method as an additional step in somatic mutation calling using whole-exome sequencing data with blood samples as controls .

Suggestions

Du même auteur

Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis

Archive ouverte | Lefebvre, Celine | CCSD

International audience. BACKGROUND: Major advances have been achieved in the characterization of early breast cancer (eBC) genomic profiles. Metastatic breast cancer (mBC) is associated with poor outcomes, yet limit...

Oncogenic Fusions May Be Frequently Present at Resistance of EGFR Tyrosine Kinase Inhibitors in Patients With NSCLC: A Brief Report

Archive ouverte | Enrico, Diego | CCSD

International audience. Introduction: Despite initial benefit, virtually all patients suffering from EGFR-mutant NSCLC experience acquired resistance to tyrosine kinase inhibitors (TKIs), driven by multiple mechanis...

Oncogenic Fusions May Be Frequently Present at Resistance of EGFR Tyrosine Kinase Inhibitors in Patients With NSCLC: A Brief Report

Archive ouverte | Enrico, Diego | CCSD

International audience

Chargement des enrichissements...